Literature DB >> 16684767

High dynamic range characterization of the trauma patient plasma proteome.

Tao Liu1, Wei-Jun Qian, Marina A Gritsenko, Wenzhong Xiao, Lyle L Moldawer, Amit Kaushal, Matthew E Monroe, Susan M Varnum, Ronald J Moore, Samuel O Purvine, Ronald V Maier, Ronald W Davis, Ronald G Tompkins, David G Camp, Richard D Smith.   

Abstract

Although human plasma represents an attractive sample for disease biomarker discovery, the extreme complexity and large dynamic range in protein concentrations present significant challenges for characterization, candidate biomarker discovery, and validation. Herein we describe a strategy that combines immunoaffinity subtraction and subsequent chemical fractionation based on cysteinyl peptide and N-glycopeptide captures with two-dimensional LC-MS/MS to increase the dynamic range of analysis for plasma. Application of this "divide-and-conquer" strategy to trauma patient plasma significantly improved the overall dynamic range of detection and resulted in confident identification of 22,267 unique peptides from four different peptide populations (cysteinyl peptides, non-cysteinyl peptides, N-glycopeptides, and non-glycopeptides) that covered 3,654 different proteins with 1,494 proteins identified by multiple peptides. Numerous low abundance proteins were identified, exemplified by 78 "classic" cytokines and cytokine receptors and by 136 human cell differentiation molecules. Additionally a total of 2,910 different N-glycopeptides that correspond to 662 N-glycoproteins and 1,553 N-glycosylation sites were identified. A panel of the proteins identified in this study is known to be involved in inflammation and immune responses. This study established an extensive reference protein database for trauma patients that provides a foundation for future high throughput quantitative plasma proteomic studies designed to elucidate the mechanisms that underlie systemic inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684767      PMCID: PMC1783978          DOI: 10.1074/mcp.M600068-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  59 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 2.  Inflammation and therapeutic vaccination in CNS diseases.

Authors:  Howard L Weiner; Dennis J Selkoe
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

3.  Clinical proteomics: written in blood.

Authors:  Lance A Liotta; Mauro Ferrari; Emanuel Petricoin
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

4.  Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins.

Authors:  Brett A Chromy; Arlene D Gonzales; Julie Perkins; Megan W Choi; Michele H Corzett; Brian C Chang; Christopher H Corzett; Sandra L McCutchen-Maloney
Journal:  J Proteome Res       Date:  2004 Nov-Dec       Impact factor: 4.466

5.  Characterization of the human blood plasma proteome.

Authors:  Yufeng Shen; Jeongkwon Kim; Eric F Strittmatter; Jon M Jacobs; David G Camp; Ruihua Fang; Nikola Tolié; Ronald J Moore; Richard D Smith
Journal:  Proteomics       Date:  2005-10       Impact factor: 3.984

Review 6.  Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic.

Authors:  Olivia Scaros; Richard Fisler
Journal:  Biotechniques       Date:  2005-04       Impact factor: 1.993

7.  Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.

Authors:  Hua Liao; Jiang Wu; Eric Kuhn; Wendy Chin; Betty Chang; Michael D Jones; Steve O'Neil; Karl R Clauser; Johann Karl; Fritz Hasler; Ronenn Roubenoff; Werner Zolg; Brad C Guild
Journal:  Arthritis Rheum       Date:  2004-12

8.  Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid.

Authors:  Yan Hu; James P Malone; Anne M Fagan; R Reid Townsend; David M Holtzman
Journal:  Mol Cell Proteomics       Date:  2005-09-30       Impact factor: 5.911

9.  Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification.

Authors:  Wen-Hai Jin; Jie Dai; Su-Jun Li; Qi-Chang Xia; Han-Fa Zou; Rong Zeng
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

10.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

View more
  82 in total

1.  Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size.

Authors:  Haizhen Zhang; Kristin E Burnum; Maria L Luna; Brianne O Petritis; Jong-Seo Kim; Wei-Jun Qian; Ronald J Moore; Alejandro Heredia-Langner; Bobbie-Jo M Webb-Robertson; Brian D Thrall; David G Camp; Richard D Smith; Joel G Pounds; Tao Liu
Journal:  Proteomics       Date:  2011-11-04       Impact factor: 3.984

Review 2.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

3.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

4.  Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.

Authors:  Chengjian Tu; Jun Li; Rebeccah Young; Brian J Page; Frank Engler; Marc S Halfon; John M Canty; Jun Qu
Journal:  Anal Chem       Date:  2011-05-26       Impact factor: 6.986

5.  Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes.

Authors:  Zhijun Cao; Hsin-Yao Tang; Huan Wang; Qin Liu; David W Speicher
Journal:  J Proteome Res       Date:  2012-05-18       Impact factor: 4.466

Review 6.  Accurate mass measurements in proteomics.

Authors:  Tao Liu; Mikhail E Belov; Navdeep Jaitly; Wei-Jun Qian; Richard D Smith
Journal:  Chem Rev       Date:  2007-07-25       Impact factor: 60.622

Review 7.  Translational systems biology: introduction of an engineering approach to the pathophysiology of the burn patient.

Authors:  Gary An; James Faeder; Yoram Vodovotz
Journal:  J Burn Care Res       Date:  2008 Mar-Apr       Impact factor: 1.845

8.  Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure.

Authors:  Hailong Song; Mei Chen; Chen Chen; Jiankun Cui; Catherine E Johnson; Jianlin Cheng; Xiaowan Wang; Russell H Swerdlow; Ralph G DePalma; Weiming Xia; Zezong Gu
Journal:  J Neurotrauma       Date:  2019-01-14       Impact factor: 5.269

9.  Comparison of multidimensional shotgun technologies targeting tissue proteomics.

Authors:  Xueping Fang; Brian M Balgley; Weijie Wang; Deric M Park; Cheng S Lee
Journal:  Electrophoresis       Date:  2009-12       Impact factor: 3.535

10.  Cerebrospinal fluid proteome of patients with acute Lyme disease.

Authors:  Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren
Journal:  J Proteome Res       Date:  2012-08-31       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.